Alamar Biosciences, Inc. (California) (ALMR)
32.69
-0.11
(-0.34%)
USD |
NASDAQ |
Sep 28, 16:00
32.69
0.00 (0.00%)
After-Hours: 16:19
Alamar Biosciences Research and Development Expense (TTM) : 44.03M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 44.03M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| 10X Genomics, Inc. | 226.80M |
| Personalis, Inc. | 56.12M |
| Adaptive Biotechnologies Corp. | 80.01M |
| Champions Oncology, Inc. | 9.346M |
| Medpace Holdings, Inc. | -- |